Radiopharmaceutical Therapy in Benign and Malignant Diseases: Radiotheragnostic Practicum

09/25/20 - 09/26/20
Wynn Las Vegas | Las Vegas, NV

AMA PRA Category 1 Credit(s)™: 12.25

Category A CE Credits:

NO RISK REGISTRATION!
All of these educational activities will be held in person or via webcast. Should the in person meeting not be possible you will have the option to participate in the virtual meeting, receive a tuition credit, or a full refund.
 

Register Below for Live Meeting or 
Click Here to Register for the Live Webcast


Each meeting registrant must have, and be registered under their own account, in order to obtain CME.

RTP20

Place Your Order

DescriptionPriceQuantity
Physicians
Scientists
Company Representatives
$ 1195
P.A./R.A.
Technologists
Retired Physicians
Sonographers
Active Military *
VA Physicians *
$ 875
Residents *
Fellows *

* Must receive letter from your director certifying status - IF LETTER IS NOT RECEIVED WITHIN 7 DAYS OF REGISTRATION YOU WILL BE CHARGED THE ADDITIONAL FEE! Please email letter to info@edusymp.com

Electronic syllabus is for registrants of the meeting or webcast ONLY
$ 597

Syllabus

Syllabus typeProduct Group IDPriceQuantity
Electronic Syllabus (Registrants ONLY)170$ 0
Full Color Printed Syllabus (Advanced Purchase Only)170$ 95

Syllabus

NO RISK REGISTRATION!
All of these educational activities will be held in person or via webcast. Should the in person meeting not be possible you will have the option to participate in the virtual meeting, receive a tuition credit, or a full refund.
About The Meeting
The purpose of this CME course is to deliver to the audience the best practices in the growing field of radiotheragnostics (aka theranostics or theragnostics) for benign and malignant diseases, beginning with the fundamentals and extending to include their advanced clinical applications. The symposium has gathered an outstanding faculty with a vast practical and scientific experience in their designated topics. The overarching goal of each faculty is to arm the audience with the most comprehensive, relevant, and up-to-date knowledge, enabling them to optimally manage common as well as some unusual therapeutic challenges in their own practices. The symposium is intentionally structured to allocate each topic the attention and time that reflects the relative complexity and anticipated need in the nuclear medicine therapy practice. It includs some of the historically established therapies but optimally modernized as well as the recently introduced state-of-the-art modalities into the United States health care. The expert faculty will discuss the optimization of the radiotheragnostic practices for best utilization of various radiopharmaceuticals in contemporary health care delivery systems, both academic and private practice settings.

Target Audience
This meeting is designed for nuclear medicine physicians, nuclear radiologists, oncologists, nuclear medicine technologists, health physicists, and radiopharmacists.

Educational Objectives
Attendees should, at the completion of this course, be able to:
  • The difference between the radiotheragnostic approach and various other concepts guiding the therapeutic delivery of radiation to the target tissues with the objective of improving health outcomes.
  • The best therapeutic practice approaches to hyperthyroidism and other benign thyroid diseases, based on evidence and/or sound medical judgment.
  • The best therapeutic practice approaches to differentiated thyroid carcinoma, based on evidence and/or sound medical judgment.
  • The optimal applications of Y-90 Ibritumomab Tiuxetan for therapy of lymphoma.
  • The optimal applications of I-131 Iobenguane to diagnostic imaging and therapy of Pheochromocytoma and Paraganglioma.
  • The optimal applications of Y-90 Resin and Glass Microspheres to radioembolization therapy of liver cancers.
  • The optimal applications of Y-90 Resin and Glass Microspheres to radioembolization therapy of liver cancers.
  • The optimal approach to diagnostic imaging of recurrent and metastatic prostate cancer.
  • The best approach to therapy of skeletal metastatic disease using various Bone-Seeking radiopharmaceuticals.
  • The practical examples for evaluation of not listed cancers for radiotheragnostics-based trials.
  • Best approaches to building radiotheragnostic practice in academic institutions.
  • Best approaches to building radiotheragnostic practice in private practice settings.
No special educational preparation is required for this CME activity.

Course Organization
This program is planned and organized by Educational Symposia, a leader in continuing medical education since 1975.

Acknowledgement
Educational Symposia appreciates our corporate supporters and exhibitors. A list of industry supporters will be provided and acknowledged at the meeting.

Registration & Cancellation Information
Early registration is strongly suggested as capacity may be limited. We will accept registrations on a first-come basis due to possible restriction on the number of registrants able to attend this course in person. Should you register to attend the meeting in-person and the meeting is not able to proceed as a live event, you will have the option to participate in the virtual meeting, receive a tuition credit, or a full refund.
Disclaimer
Educational Symposia (ESI) as planner and presenter of this meeting, and Professional Travel as the official travel agency for this meeting, claim no liability for the acts of any suppliers or the safety of any attendees while in transit to, from, or during this event or any optional activities. The total amount of liability, if any, for the meeting organizer is limited to a refund of the registration fee, and Professional Travel's responsibility is limited to that of an agent.

Special Note for the Disabled
Educational Symposia wishes to ensure that no individual with a disability is excluded, denied services, segregated or otherwise treated differently from other individuals because of the absence of auxiliary aids and services. If you need any auxiliary aids or services identified in the Americans with Disabilities Act, please contact our office at (813) 806-1000.
Scientific Sponsor
Educational Symposia
Meeting Accreditation
Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Educational Symposia designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Technologists: This program has been submitted to the ASRT.  The number of A CE credits will be available approximately 30 days prior to the meeting.  Please visit www.edusymp.com or call 813-806-1000 regarding the availability of Category A CE credit.
 
Program Director: Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD

Samuel Mehr, M.D.
Diplomate, American Board of Nuclear Medicine
Systemic Radiation Therapy and Theranostics
Nebraska Cancer Specialists
Omaha, NE

Erik S. Mittra, M.D., Ph.D.
Associate Professor, Diagnostic Radiology
Division Chief, Nuclear Medicine & Molecular Imaging
Oregon Health & Science University
Portland, OR

Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD
Professor of Radiology and Medicine
Associate Director, Nuclear Medicine
Penn State University
Milton S. Hershey Medical Center
Hershey, PA

Terence Z. Wong, M.D., Ph.D.
Chief, Division of Nuclear Medicine
Professor of Radiology
Department of Radiology
Duke Cancer Institute
Medical Physics Graduate Program
Durham, NC
FRIDAY, SEPTEMBER 25, 2020
  7:00 8:00 AM Registration and Continental Breakfast for Registrants
         
  8:00 8:10 Welcome and Morning Announcements
        Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD
         
  8:10 9:10 History & Practice of Radioiodine Therapy in Hyperthyroidism
        Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD
         
  9:10 9:45 Therapy for Lymphoma with Y-90 Ibritumomab Tiuxetan
        Terence Z. Wong, M.D., Ph.D. 
         
  9:45 10:30 Radioiodine Therapy: Uncommon Benign Thyroid Conditions
        Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD
         
  10:30 10:45 Coffee Break for Registrants
         
  10:45 - 11:30 I-131 Iobenguane Imaging & Therapy for Pheochromocytoma/Paraganglioma
        Erik S. Mittra M.D., Ph.D. 
         
  11:30 12:15 PM Radioiodine in Thyroid Cancer - Basics
        Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD
         
  12:15 1:30 Lunch on Your Own
         
  1:30 2:15 Radioiodine in Thyroid Cancer - Advanced
        Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD
         
  2:15 3:00 Radioembolization Therapy with Y-90 Resin and Glass Microspheres
        Terence Z. Wong, M.D., Ph.D. 
         
  3:00 3:45 Ga-68/Lu-177 Dotatate Imaging/Therapy of Neuroendocrine Tumors
        Erik S. Mittra M.D., Ph.D. 
         
  3:45 4:00 Question and Answer Session
        Faculty
         
  4:00     End of Session
         
SATURDAY, SEPTEMBER 26, 2020
  7:30 8:00 AM Continental Breakfast for Registrants
         
  8:00 8:45 Diagnostic Imaging of Recurrent and Metastatic Prostate Cancer
        Samuel Mehr, M.D. 
         
  8:45 9:30 Therapy for Skeletal Metastatic Disease with Bone-Seeking Agents
        Terence Z. Wong, M.D., Ph.D. 
         
  9:30 10:15 USA Trials Experience with Lu-177 PSMA-617 in Prostate Cancer
        Terence Z. Wong, M.D., Ph.D. 
         
  10:15 10:30 Coffee Break for Registrants
         
  10:30 11:15 Pivotal Trials in the USA for Up-and-Coming Radiotheragnostics
        Erik S. Mittra M.D., Ph.D. 
         
  11:15 12:00 PM Opportunities for Somatostatin Receptor Targeting in Avid Cancers
        Samuel Mehr, M.D. 
         
  12:00 1:00 Lunch on Your Own
         
  1:00 1:50 Building Nuclear Medicine Therapy Program in Academic Practice
        Erik S. Mittra M.D., Ph.D. 
         
  1:50 2:45 Building Nuclear Medicine Therapy Program in Private Practice
        Samuel Mehr, M.D. 
         
  2:45 3:00 Question and Answer Session
        Faculty
         
  3:00     End of course
         
        Faculty & topics subject to change.
         
Wynn Las Vegas

About The Hotel
Wynn Resorts holds more Forbes Travel Guide Five-Star Awards than any other independent hotel company in the world. At Wynn Las Vegas, you have your choice of celebrated rooms and suites each designed for a serene and stylish retreat.

With unique salons, luxury shopping, exquisite resort pools and a team of concierges to assist with your every need, you'll find all you are looking for.

The collection of fine dining restaurants are not only the best experiences to be had in Las Vegas, but some of the best to be had in the world.

From large production shows and spellbinding displays, to live music and once-in-a-lifetime chances at adventure, the opportunities abound for memories to be made that will last forever.

How to Get There
Fly directly to McCarran International Airport, located just 15 minutes south of Wynn Las Vegas. Daily national and international non-stop flights are available.

Hotel Cut-Off Date: August 24, 2020
Group Rates 3 Days Prior/Post meeting – Space Available Basis and confirmation by the hotel

Space is Limited – Reserve Today: Call Wynn Las Vegas for Reservations at: (866)770-7555 and provide Group Code: 8EDU0920 to receive the group discount or book online here. Call Professional Travel at 813-806-1050 for further assistance.

Group Room Rates:
Delux Resort Guestroom...Start At $279.00/nt. (Single/Double Occupancy)
Each additional person over double occupancy is $50.00 per night

Room Preferences:
King Bed/Two Double Beds upon availability
(Charge of $30 per room per night for two doubles accommodations)

Hotel Tax: 13.38%

Resort Fee: $39 plus 13.38% Tax.

Deposit Policy: Credit cards will be charged first night room and tax charges at time of reservation.

Cancellation Policy: All cancellations, arrival and departure date changes must be made 72 hours or more prior to scheduled arrival date/time to avoid penalties. Check in time is: 3:00 PM; Check out time is 12:00 PM.

Hotel: Wynn Las Vegas
3131 Las Vegas Blvd, South
Las Vegas, Nevada 89109

PH: (702)770-7000